Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11661411
Quinoxaline compounds and uses thereof
granted -
US 11661439
Peptide hydrogels and use thereof
granted -
US 11661459
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted -
US 11661461
Phospho-Rab antibodies, assays and methods of use thereof
granted -
US 11661593
Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
granted -
US 11660276
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 11661601
Methods for modulating FMR1 expression
granted -
US 11661617
Processes for the production of tryptamines
granted -
US 11660274
Dosage forms and methods for enantiomerically enriched or pure bupropion
granted -
CA 3235096
METHODES DE TRAITEMENT DE L'ANEMIE CAUSEE PAR UNE MALADIE RENALE
granted -
US 11654142
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11654097
Peptide having activities of skin whitening and uses thereof
granted -
US 11654157
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation
granted -
US 11654128
Methods and compositions for treating ectoparasite infestations
granted -
US 11655307
Anti-doublecortin-like kinase 1 antibodies and methods of use
granted -
US 11655288
Antibodies to oxidized phospholipids
granted -
US 11655291
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A
granted -
US 11654145
Combination therapy involving diaryl macrocyclic compounds
granted -
US 11655286
Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof
granted -
US 11655248
Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor
granted -
US 11654124
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
granted -
US 11655454
Method and apparatus for improved mesenchymal stem cell harvesting
granted -
US 11655241
Heterocyclic compound and use thereof
granted -
US 11654166
Therapeutic bacteriophage compositions for treating Staphylococcus infection
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.